Skip to main content
NIH funding notice RFA-HL-15-007

Developing Improved Assessments of Tissue Oxygenation (R41)

Closed on June 30, 2014.

Posted
April 15, 2014
Close date
June 30, 2014
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

Competing awards, new and renewals, since FY2014, under this notice and the notices it replaced.

Past awards
1
1 new
First-year cost
$150,000
Institutions
1
1 contact PI

Awards by fiscal year

Fiscal years 2014 to 2026.

Most frequent institutions

  1. OPTICYTE, INC.1

Most frequent study sections

  1. Special Emphasis Panel (ZHL1 CSR-I (F1))1
1 award under RFA-HL-15-007 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
FY2015Real-time myoglobin saturation measurement to assess benefit of RBC transfusion1R41HL127543-01Arakaki, Lorilee S. L.OPTICYTE, INC., WAFirst-year cost $150,000Study section ZHL1
Newest fiscal year first, then first-year cost.

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-13-0.3.2. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for departments

Open NIH notices that fit your faculty

See which open NIH funding notices fit each faculty member's CV, why each fits, and who won before.